Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. [electronic resource]
Producer: 20160801Description: 2402-11 p. digitalISSN:- 1474-547X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor -- analysis
- Bone Marrow Neoplasms -- drug therapy
- Burkitt Lymphoma -- chemistry
- Central Nervous System Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- France
- Humans
- Hydrocortisone -- administration & dosage
- Injections, Intravenous
- Male
- Methotrexate -- administration & dosage
- Methylprednisolone -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Odds Ratio
- Patient Selection
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Rituximab -- administration & dosage
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.